Silence Therapeutics Plc (SLNCF)
3.85
0.00 (0.00%)
USD |
OTCM |
Oct 16, 16:00
Silence Therapeutics Cash from Operations (Annual) : -62.27M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -62.27M |
| December 31, 2024 | -67.64M |
| December 31, 2023 | -49.46M |
| December 31, 2022 | -55.96M |
| December 31, 2021 | 9.374M |
| December 31, 2020 | -13.65M |
| December 31, 2019 | 2.142M |
| December 31, 2018 | -22.30M |
| December 31, 2017 | -12.38M |
| December 31, 2016 | -13.36M |
| December 31, 2015 | -12.34M |
| December 31, 2014 | -15.34M |
| December 31, 2013 | -10.50M |
| December 31, 2012 | -7.701M |
| December 31, 2011 | -8.149M |
| Date | Value |
|---|---|
| December 31, 2010 | -16.23M |
| December 31, 2009 | -7.181M |
| December 31, 2008 | -12.33M |
| December 31, 2007 | -6.655M |
| December 31, 2006 | -6.840M |
| December 31, 2005 | -4.692M |
| December 31, 2004 | -4.299M |
| December 31, 2003 | -3.325M |
| December 31, 2002 | -2.762M |
| December 31, 2001 | -3.287M |
| December 31, 2000 | -4.326M |
| December 31, 1999 | -1.834M |
| December 31, 1998 | -2.994M |
| December 31, 1997 | -2.488M |
| December 31, 1996 | -1.134M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Biodexa Pharmaceuticals Plc | -7.268M |
| NuCana Plc | -9.377M |
| Mereo BioPharma Group Plc | -31.04M |
| Compass Pathways Plc | -157.61M |
| HemoGenyx Pharmaceuticals Plc | -4.543M |